Salivary concentrations of hexamethylene bisacetamide (HMBA) in patients receiving 5-day continuous infusions.

Conley, B A

Salivary concentrations of hexamethylene bisacetamide (HMBA) in patients receiving 5-day continuous infusions. [electronic resource] - Cancer chemotherapy and pharmacology 1988 - 65-8 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0344-5704

10.1007/BF00254184 doi


Acetamides--administration & dosage
Dose-Response Relationship, Drug
Drug Administration Schedule
Humans
Infusions, Intravenous
Saliva--analysis
Time Factors